A Study of LNK01001 Capsule in Patients With Moderate to Severe Atopic Dermatitis
Clinical trial NCT06085521 · COMPLETED
Trial details
- NCT number
- NCT06085521
- Sponsor
- Lynk Pharmaceuticals Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-26
- Primary completion
- 2023-06-14
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.